@JayShah_MD Profile picture

Jay Shah

@JayShah_MD

PGY-3 @UCLAIMChiefs through @UChiPritzker and @UnivOfKansas | @CardiacTrials Ambassador | @KUHoops & @Chiefs Fan | Amateur Photographer & Tech Nerd | #MedEd

Joined June 2020
Similar User
Lola Akingbade, MD photo

@LolaAkingbade

olivier photo

@medamorxphosis

Murtala Affini photo

@AffiniMurtala

Alex Rains (she/her) photo

@AlexNRains

Tess Allan photo

@TessAllanMed

Daniel Ahn photo

@aanieldhn

Henry Liedl photo

@HenryLiedlMD

Pinned

Today is the last day of intern year. This year has been the hardest year of my life filled with hardship as well as so much growth. My dad came back from the dead. Resuscitated after 32 minutes. Life happened. During intern year.


Jay Shah Reposted

📚 HFpEF 🔹HFpEF ≠ diastolic dysfunction 1/3 of patients in PARAGON-HF did not have diastolic dysfunction on resting echo 🔹Use H2FPEF score to help diagnose HFpEF 🔹If suspicion remains high with neg H2FPEF, consider stress echo - E/e’ > 14 with stress suggests HFpEF

Tweet Image 1

Jay Shah Reposted

Congrats to third-year resident Amber Tang, MD, on her publication in @CircHF! Her research on patient outcomes after heart failure hospitalization will guide the reimplementation of @American_Heart's IMPLEMENT-HF trial. Read more here: uclahs.fyi/3AoVYMM

Tweet Image 1

Jay Shah Reposted

We just published a Coronary Artery Calcium Staging algorithm to Guide Preventive Interventions @JACCJournals authors.elsevier.com/sd/article/S27…


Jay Shah Reposted

This week’s newsletter highlights the integral role our department plays in training and mentoring the next generation of clinicians. Discover how our faculty and trainees contribute to a rich and collaborative environment of education and mentorship. uclahs.fyi/3TxAmV3

Tweet Image 1

Jay Shah Reposted

Excited to share our research on health disparities in HF patients experiencing housing insecurity, only possible with mentorship from @boback @gcfmd and many others! @uclaimchiefs

Patients with HF and housing insecurity have distinct demographic characteristics ⬆️ all-cause re🏨 risk Examining Heart Failure Outcomes Amidst Housing Insecurity sciencedirect.com/science/articl… @boback @JCardFail

Tweet Image 1


Jay Shah Reposted

HFpEF WITHOUT “diastolic dysfunction”⁉️ More common than you think ⤵️ 🖥️: coreimpodcast.com/2024/06/05/hfp…


Jay Shah Reposted

There’s something special about them… they just have that X factor ❌❌❌. Huge welcome to these 10 amazing people who are stepping into their chief roles today!! The program is in great hands 🎉🎉🎉

Tweet Image 1

Jay Shah Reposted

Q: What is the long-term implication of Lp(a) elevation in a pooled multi-ethnic US cohort? A: While diabetics are less likely to have a high Lp(a), risks were strongest in diabetes, but similar in female vs. male and by race/ethnicity bit.ly/4d1ewRR #JACC

Tweet Image 1

Jay Shah Reposted

🔑 concept: Vulnerable Plaque Often just a mild stenosis, this thin-capped lipid-rich atheroma is the most prone lesion to rupture —> MI 📚 and can be preemptively detected on cardiac CT by 4 characteristics: 🔹pos remodeling 🔹low density 🔹napkin ring 🔹spotty calcium

Tweet Image 1

Thankful for the opportunity to discuss how to improve South Asian 🫀 health starting with considering different imaging modalities for screening in this high risk population. Thank you @the_lundquist and @uclaimchiefs! Excited to continue more work in this space! #ACC24

Tweet Image 1

ULTIMATE DAPT via #ACC24! 🫀 Ticagrelor monotherapy after 1 month of DAPT post ACS w/ PCI non-inferior in regards to major adverse cardiac/cerebrovascular events w/ significant ⬇️⬇️⬇️ in major bleeding 🩸 Maybe time for guidelines to change regarding DAPT! @CardiacTrials

Tweet Image 1
Tweet Image 2

Excited to be at my first @ACCinTouch 🫀conference as a resident and present on South Asian CVD! Excited for this opportunity to learn and meet people! #ACC24 #SouthAsianCVD #CCTA #CAC #BruinHearts @uclaimchiefs


Jay Shah Reposted

It's #MatchDay2024 and we @DOM_UCLA cannot be more thrilled to welcome another exceptional class of incoming residents. Enjoy our welcome video, and to our new colleagues welcome to @UCLAHealth @dgsomucla @UCLA #internalmedicine


Jay Shah Reposted

Having an elevated Lp(a) increases your risk of heart disease. There are no currently approved therapies to Lp(a). But that doesn't mean you cannot lower your risk. Here's how 🧵👇 /1

Tweet Image 1

Jay Shah Reposted

1/ 🚨 Attention all @CardioNerds‼️ Do you want to know more about iron deficiency (ID) in heart failure (HF)? 🫀 Stay tuned for this #Tweetorial from the @JCardFail series w/edits from @AHajduczok @RawanAAmir @KarlaAsturias @AmitGoyalMD ! onlinejcf.com/article/S1071-…

Tweet Image 1

Jay Shah Reposted

1/12 Saturday Morning Class #27 Update on ongoing trials for treatment of elevated Lp(a): We will review Lp(a) drugs in development. Pelacarsen- brief story: The field of RNA therapeutics for Lp(a) started with this paper from a collaboration of our lab at UCSD and…

Tweet Image 1
Tweet Image 2

Jay Shah Reposted

Congratulations!!! 🎉

Tweet Image 1

Jay Shah Reposted

Wow. Unmeasurable levels of Lp(a) up to 9 months with single dose of @EliLillyandCo’s lepodisiran (up to -94% out to almost a year). #AHA2023

Tweet Image 1

Jay Shah Reposted

Such an important paper showing increased CAC slope the steepest among SA, correlating with the high risk of DM and CVD in this population.

Our much awaited paper from #MESA & #MASALA ❤️. Diabetes ⬆️ likelihood CAC in #SouthAsians (SA) & Whites. Clinically significant > 100 CAC in SA & Chinese. ⬆️ fasting glucose ⬆️CAC in SA. Led by Dr. Premyodhin. @DrNathanWong @BudoffMd @alka_kanaya pubmed.ncbi.nlm.nih.gov/37795703/

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Loading...

Something went wrong.


Something went wrong.